Immunome (IMNM) Times Interest Earned (2019 - 2020)

Immunome (IMNM) has 8 years of Times Interest Earned data on file, last reported at -$0.32 in Q1 2026.

• Quarterly Times Interest Earned rose 99.81% year-over-year to -$0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.29 (up 99.57% YoY) and the FY2025 annual result came in at -$1.24, up 56.71% from the prior year.
• Times Interest Earned rose to -$0.32 in Q1 2026, from -$14572.2 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of -$0.32 in Q1 2026 to a low of -$14572.2 in Q4 2025.
• A 5-year average of -$1062.9 and a median of -$4.96 in 2022 frame the typical range for Times Interest Earned.
• Annual changes were most pronounced in 2023 — Times Interest Earned sank 5624.73% — and 2026, when it jumped 99.81%.
• Tracing IMNM's Times Interest Earned over 5 years: stood at -$26.67 in 2022, then slumped by 5624.73% to -$1526.7 in 2023, then jumped by 81.88% to -$276.57 in 2024, then slumped by 5168.96% to -$14572.2 in 2025, then jumped by 100.0% to -$0.32 in 2026.
• The last three Times Interest Earned figures came in at -$0.32 (Q1 2026), -$14572.2 (Q4 2025), and -$1.44 (Q3 2025), per Business Quant data.